Myomo, Inc. to Report Second Quarter 2017 Results on August 14, 2017

11Aug

Myomo, Inc. to Report Second Quarter 2017 Results on August 14, 2017

Portfolio News

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will release its unaudited financial results for the quarter ended June 30, 2017 on Monday, August 14, 2017, after the US markets close. Read more >>

Share this post

Related Posts

17Nov

Client Success Stories – Archer Roose

Going into 2020, Archer Roose was growing at around 100% year-over-year. The brand had just taken flight aboard JetBlue, being... read more
08Sep

Second-generation vaccines offer a chance to correct flaws in early vaccination campaigns

...The vaccine candidate known as AKS-452, from Massachusetts-based Akston Biosciences, is one promising example of a jab which could address... read more
18Jul

5 Creative Ways Female Founders Fund Their Startups

You’ve heard of crowdfunding. What about equity crowdfunding? Read more >> read more
06Jan

Regroup Mass Notification Wins 2020 Unified Communications Product of the Year Award

Regroup Mass Notification, a trusted provider of emergency and day-to-day communication solutions, today announced that it has been chosen by... read more
29Mar

Why Toy-Sharing Subscriptions Are the Best Thing for Families

No matter how much your little one begs for a toy, chances are it'll be forgotten in the corner of... read more
03Aug

Blind man, 51, watches his football team for the first time in 27 years thanks to pioneering glasses technology only to see them get thrashed 5-1

Brian Casey, 51, wears a groundbreaking visual aid technology called eSight He went to watch Fleetwood Town for the... read more
06May

LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures

LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant... read more
16Dec

New Research Study Shows Efficacy of Sustained Acoustic Medicine as Add-on Therapy in Treating Sport-Related Injuries and Returning Athletes to Play

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, was recently evaluated... read more
03Aug

RevBio Receives FDA Approval to Conduct its Second U.S.-Based Clinical Trial for Dental Implant Stabilization

RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a 20-patient clinical... read more
13Jun

Entrepreneur sells house to fund biz, later secures millions from investors

EcoSoul Home Inc, which has recently secured $10 million - Series A round led by Accel and Singh Capital Partners,... read more